Pricing

Kezar Life Sciences Inc (KZR)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: John Fowler
Employees: 60
Web site: kezarlifesciences.com
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
650-822-5600
Stock Split History
Date Ratio
2024-10-30 1:10
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Kezar Life Sciences, Inc. engages in the discovery and development of novel small molecule therapeutics. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available